[1] [1] Hunter DJ, Bierma-Zeinstra S. Osteoarthritis[J]. Lancet, 2019, 393(10182): 1745-1759.

[2] [2] Han S. Osteoarthritis year in review 2022: biology[J]. Osteoarthritis Cartilage, 2022, 30(12): 1575-1582.

[3] [3] Zhang H, Cai D, Bai X. Macrophages regulate the progression of osteoarthritis[J]. Osteoarthritis Cartilage, 2020, 28(5): 555-561.

[4] [4] Li W, Zhou Y, Han L, et al. Calcium signaling of primary chondrocytes and ATDC5 chondrogenic cells under osmotic stress and mechanical stimulation[J]. J Biomech, 2022, 145: 111388.

[5] [5] Vian A, Pochitaloff M, Yen ST, et al. In situ quantification of osmotic pressure within living embryonic tissues[J]. Nat Commun, 2023, 14(1): 7023.

[6] [6] Zimmerman BK, Nims RJ, Chen A, et al. Direct osmotic pressure measurements in articular cartilage demonstrate nonideal and concentration-dependent phenomena[J]. J Biomech Eng, 2021, 143(4): 041007.

[7] [7] Schneiderman R, Keret D, Maroudas A. Effects of mechanical and osmotic pressure on the rate of glycosaminoglycan synthesis in the human adult femoral head cartilage: an in vitro study[J]. J Orthop Res, 1986, 4(4): 393-408.

[8] [8] Urban JP, Bayliss MT. Regulation of proteoglycan synthesis rate in cartilage in vitro: influence of extracellular ionic composition[J]. Biochim Biophys Acta, 1989, 992(1): 59-65.

[9] [9] Hopewell B, Urban JPG. Adaptation of articular chondrocytes to changes in osmolality[J]. Biorheology, 2003, 40(1/2/3): 73-77.

[10] [10] Tew SR, Peffers MJ, McKay TR, et al. Hyperosmolarity regulates SOX9 mRNA posttranscriptionally in human articular chondrocytes[J]. Am J Physiol Cell Physiol, 2009, 297(4): C898-C906.

[11] [11] Zhang Q, Ji Q, Wang X, et al. SOX9 is a regulator of ADAMTSs-induced cartilage degeneration at the early stage of human osteoarthritis[J]. Osteoarthritis Cartilage, 2015, 23(12): 2259-2268.

[12] [12] Alinezhad-Bermi S, Kabiri M, Rad I, et al. Hyperosmolarity benefits cartilage regeneration by enhancing expression of chondrogenic markers and reducing inflammatory markers[J]. In Vitro Cell Dev Biol Anim, 2021, 57(3): 290-299.

[13] [13] Cacace VI, Finkelsteyn AG, Tasso LM, et al. Regulatory volume increase and regulatory volume decrease responses in HL-1 atrial myocytes[J]. Cell Physiol Biochem, 2014, 33(6): 1745-1757.

[14] [14] Amin AK, Huntley JS, Simpson AHRW, et al. Increasing the osmolarity of joint irrigation solutions may avoid injury to cartilage: a pilot study[J]. Clin Orthop Relat Res, 2010, 468(3): 875-884.

[15] [15] Chen Y, Yan Y, Tian R, et al. Chemically programmed metabolism drives a superior cell fitness for cartilage regeneration[J]. Sci Adv, 2024, 10(37): eadp4408.

[16] [16] Charlestin V, Fulkerson D, Arias Matus CE, et al. Aquaporins: new players in breast cancer progression and treatment response[J]. Front Oncol, 2022, 12: 988119.

[17] [17] Mariajoseph-Antony LF, Kannan A, Panneerselvam A, et al. Role of aquaporins in inflammation-a scientific curation[J]. Inflammation, 2020, 43(5): 1599-1610.

[18] [18] Gao H, Gui J, Wang L, et al. Aquaporin 1 contributes to chondrocyte apoptosis in a rat model of osteoarthritis[J]. Int J Mol Med, 2016, 38(6): 1752-1758.

[19] [19] Yan T, Liu J. Transmembrane ion channels: from natural to artificial systems[J]. Angew Chem Int Ed, 2025, 64(1): e202416200.

[20] [20] Lewis R, May H, Mobasheri A, et al. Chondrocyte channel transcriptomics: do microarray data fit with expression and functional data[J]. Channels (Austin), 2013, 7(6): 459-467.

[21] [21] Fu S, Meng H, Inamdar S, et al. Activation of TRPV4 by mechanical, osmotic or pharmaceutical stimulation is anti-inflammatory blocking IL-1 mediated articular cartilage matrix destruction[J]. Osteoarthritis Cartilage, 2021, 29(1): 89-99.

[22] [22] Kurita T, Yamamura H, Suzuki Y, et al. The ClC-7 chloride channel is downregulated by hypoosmotic stress in human chondrocytes[J]. Mol Pharmacol, 2015, 88(1): 113-120.

[23] [23] Hall AC. The role of chondrocyte morphology and volume in controlling phenotype-implications for osteoarthritis, cartilage repair, and cartilage engineering[J]. Curr Rheumatol Rep, 2019, 21(8): 38.

[24] [24] Kerrigan MJP, Hook CSV, Qusous A, et al. Regulatory volume increase (RVI) by in situ and isolated bovine articular chondrocytes[J]. J Cell Physiol, 2006, 209(2): 481-492.

[25] [25] Jaggi AS, Kaur A, Bali A, et al. Expanding spectrum of sodium potassium chloride co-transporters in the pathophysiology of diseases[J]. Curr Neuropharmacol, 2015, 13(3): 369-388.

[26] [26] Halterman JA, Kwon HM, Wamhoff BR. Tonicity-independent regulation of the osmosensitive transcription factor TonEBP (NFAT5)[J]. Am J Physiol Cell Physiol, 2012, 302(1): C1-C8.

[27] [27] Hiyama A, Gajghate S, Sakai D, et al. Activation of TonEBP by calcium controls{beta}1, 3-glucuronosyltransferase-I expression, a key regulator of glycosaminoglycan synthesis in cells of the intervertebral disc[J]. J Biol Chem, 2009, 284(15): 9824-9834.

[28] [28] Lee J, Lee J, Lee S, et al. Genetic deficiency of nuclear factor of activated T cells 5 attenuates the development of osteoarthritis in mice[J]. Joint Bone Spine, 2022, 89(1): 105273.

[29] [29] van der Windt AE, Haak E, Das RHJ, et al. Physiological tonicity improves human chondrogenic marker expression through nuclear factor of activated T-cells 5 in vitro[J]. Arthritis Res Ther, 2010, 12(3): R100.

[30] [30] Lefebvre V, Smits P. Transcriptional control of chondrocyte fate and differentiation[J]. Birth Defects Res C Embryo Today, 2005, 75(3): 200-212.

[32] [32] Haneda M, Hayashi S, Matsumoto T, et al. Depletion of aquaporin 1 decreased ADAMTS-4 expression in human chondrocytes[J]. Mol Med Rep, 2018, 17(4): 4874-4882.

[33] [33] Eltawil NM, Howie SM, Simpson AW, et al. The use of hyperosmotic saline for chondroprotection: implications for orthopaedic surgery and cartilage repair[J]. Osteoarthritis Cartilage, 2015, 23(3): 469-477.